Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
RO-7875913 in Relapse multiple myeloma: NCT07342114 Clinical Landscape Report 2026
28 September 2026
NCT07342114 clinical landscape for Relapse multiple myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CD64 Targeting CAR-T(University of Colorado) in Relapsing acute myeloid leukemia: NCT07347418 Clinical Landscape Report 2026
28 September 2026
NCT07347418 clinical landscape for Relapsing acute myeloid leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white spac…
9 min read
Enfortumab Vedotin-ejfv in Bladder Cancer: NCT07346053 Clinical Landscape Report 2026
28 September 2026
NCT07346053 clinical landscape for Bladder Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Apremilast in Psoriasis: NCT07352566 Clinical Landscape Report 2026
28 September 2026
NCT07352566 clinical landscape for Psoriasis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Ziftomenib in Acute myeloid leukaemia with 11q23 abnormality: NCT07355335 Clinical Landscape Report 2026
28 September 2026
NCT07355335 clinical landscape for Acute myeloid leukaemia with 11q23 abnormality: endpoints, sponsor, phase, geography, readouts, asset context and developm…
9 min read
Hexagen in Eczema: NCT07355075 Clinical Landscape Report 2026
28 September 2026
NCT07355075 clinical landscape for Eczema: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Revumenib in Acute Myeloid Leukemia: NCT07356154 Clinical Landscape Report 2026
28 September 2026
NCT07356154 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
PRA-523 in Pruritus: ISRCTN63487177 Clinical Landscape Report 2026
28 September 2026
ISRCTN63487177 clinical landscape for Pruritus: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Cyclophosphamide in Acute Myeloid Leukemia: NCT07359859 Clinical Landscape Report 2026
28 September 2026
NCT07359859 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
KD01 in Bladder Cancer: NCT07359235 Clinical Landscape Report 2026
28 September 2026
NCT07359235 clinical landscape for Bladder Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anti-CLL1-CD33-NKG2D Bicephali CAR-T(Yake) in Acute Myeloid Leukemia: NCT07370064 Clinical Landscape Report 2026
28 September 2026
NCT07370064 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Venetoclax in Acute Myeloid Leukemia: NCT07358195 Clinical Landscape Report 2026
28 September 2026
NCT07358195 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.